ER Responsive Luciferase Reporter T47D Stable Cell Line is derived from human breast cancer,and stably express firefly luciferase reporter gene under the control of the ER response element. This cell line is an ideal cellular model for monitoring the activation of Estrogen Receptor Signaling Pathway triggered by stimuli treatment, enforced gene expression and gene knockdown.
Estrogen receptor (ER) belongs to nuclear receptor family and plays a widespread role in human physiology and in the development or progression of numerous diseases. In response to estrogen stimulation, estrogen bound receptor in the nucleus dimerizes and binds to specific response elements known as estrogen response elements (EREs) located in the promoters of target genes and regulates their gene expression.
Signosis has established T47D ER luciferase reporter stable cell line, in which the ERE and reporter luciferase gene are consistently expressed in the cell line to facilitate the screening and study. This stable cell line can provide a sensitive, responsive, and rapid in vitro system to detect and measure substances with potential (anti-)estrogenic activity.
Principle behind TF luciferase reporter. TF luciferase reporter stable cell line utilizes artificial promoter constructs to drive luciferase expression. The promoter region can consists of multiple repeats of a cis-element TF binding site, a DNA fragment from the promoter region of a known TF downstream gene, or a DNA fragment containing putative/known TF binding sites. There are several ways that a TF can be activated, such as through extracellular stimuli or through intracellular signaling pathways. Once activated, the TF translocates to the nucleus and often interacts with relevant co-factors to drive gene expression. Once luciferase is expressed, it can generate light in an enzymatic assay and the amount of light measured is positively correlated with the level of TF activation.
Estrogen Receptor Luciferase Reporter T47D Stable Cell Line (2 vials)
Gómez, L., Marinov, D., Porcel-Rodríguez, E., Scaccabarozzi, D., Sanseverino, I., Sciuto, P., Narendja, F., Hornek-Gausterer, R., Lenz, K., Chalon, C., Marneffe, Y., Soldán, P., Hora, M., Leppänen, M. T., Järvistö, J., Viidanoja, J., Ait-Aissa, S., Maillot-Marechal, E., El Mais, A. E. R., … Lettieri, T. (2026). Effect-based methods and effect-based trigger values for estrogenicity monitoring in surface water: An interlaboratory study. Environmental Research, 298, 124218. https://doi.org/10.1016/j.envres.2026.124218
Sutherland, E. S., Manodara, G., Gillon, A., Stevens, K. L., Kauff, A., & Heather, A. K. (2026). Estrogenic activity in tampon products. Journal of the Endocrine Society, 10(6), bvag094. https://doi.org/10.1210/jendso/bvag094
Manodara, G., Gillon, A., Sutherland, E. S., Stevens, K. L., Deans, C. M., Kauff, A., & Heather, A. K. (2026). Functional estrogenic activity in rivers, water supply, and rainwater. iScience, 29(7), 116372. https://doi.org/10.1016/j.isci.2026.116372
Algethami, M., Shoqafi, A., Lashen, A., Alqahtani, S., Spicer, J., ALtayyar, A., Tosun, Ç., Jeyapalan, J. N., Mongan, N. P., James, V., Rakha, E. A., & Madhusudan, S. (2025). Investigation of ribociclib, abemaciclib and palbociclib resistance in ER+ breast cancer cells reveal potential therapeutic opportunities. Scientific Reports, 15(1), Article 28579. https://doi.org/10.1038/s41598-025-11052-4
Shao, Q., Duong, T. N., Park, I., & Nomura, D. K. (2023). Covalent 14-3-3 Molecular Glues and Heterobifunctional Molecules Against Nuclear Transcription Factors and Regulators. BioRxiv : The Preprint Server for Biology, 2023.11.06.565850. https://doi.org/10.1101/2023.11.06.565850
Johan Lundqvist, Persson, K. M., & Agneta Oskarsson. (2021). Glass-bottled drinking water: a time capsule to study the historic presence of hazardous chemicals using effect-based methods. Environmental Sciences Europe, 33(1). https://doi.org/10.1186/s12302-021-00476-0
Plavelil, N., Appu, A. P., Gopal, K. C., Mondal, A., Perkins, N., & Mukherjee, A. B. (2025). Defective anterograde protein-trafficking contributes to endoplasmic reticulum stress in a CLN1 disease model. Neurobiology of Disease, 209, 106890. https://doi.org/10.1016/j.nbd.2025.106890
Yabaji, S. M., Zhernovkov, V., Araveti, P. B., Lata, S., Rukhlenko, O. S., Al Abdullatif, S., Vanvalkenburg, A., Alekseyev, Y. O., Ma, Q., Dayama, G., Lau, N. C., Johnson, W. E., Bishai, W. R., Crossland, N. A., Campbell, J. D., Kholodenko, B. N., Gimelbrant, A. A., Kobzik, L., & Kramnik, I. (2025). Lipid peroxidation and type I interferon coupling fuels pathogenic macrophage activation causing tuberculosis susceptibility. eLife, 14, RP106814. https://doi.org/10.7554/eLife.106814.2
Zhao, X., Ting, S.-M., Sun, G., & Aronowski, J. (2026). Neurological recovery after ICH is mediated by the aryl hydrocarbon receptor-bilirubin interplay through improved erythrophagocytosis. Journal of Cerebral Blood Flow & Metabolism, 46(2), 605–621. https://doi.org/10.1177/0271678X251371375
Tung, M.-C., Chang, G. R.-L., Tu, M.-Y., Fan, H.-C., Yen, C.-C., Cidem, A., Chen, I.-C., & Chen, C.-M. (2026). Dual osteoprotective actions of the kefir peptide KFP-1: Enhancement of bone formation and suppression of bone resorption in cells and murine models. Calcified Tissue International, 117(1), 32. https://doi.org/10.1007/s00223-026-01487-w
Deng, C., Cai, S., Guo, C., Khan, S., Liu, L., Tian, Q., Ma, Z., Zhang, J., & Zhao, L. (2026). Dysregulation of the PATZ1/CTCF balance silences ZBTB20 to drive melanoma progression. Advanced Science, 13(26), e20917. https://doi.org/10.1002/advs.202520917
